The U.S. House of Representatives Oversight and Reform Committee is holding a hearing with current and former executives of three major drug companies on the high cost of prescription drugs in the U.S.
from Health and Science https://ift.tt/2Gc5JSy
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH
No comments:
Post a Comment